Navigation Links
Roche Introduces Immunoassay Module for cobas® 8000 Modular Analyzer Series In U.S.

INDIANAPOLIS, Oct. 29 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. introduction of the cobas e 602 analyzer, the latest addition to the cobas® 8000 modular analyzer series for diagnostic labs with high-volume workloads. Labs will now be able to combine this new immunoassay module with two existing clinical chemistry modules to create an integrated platform with 24 unique system configurations to match their specific testing needs.

"The cobas e 602 module completes our consolidated platform solution for high-volume labs by enabling them to seamlessly integrate clinical chemistry and immunoassay testing on one system," said Randy Pritchard, vice president, marketing of Roche Diagnostics Corporation. "The modular design gives them the freedom to design a system that meets their needs now and easily add individual modules as their testing needs change in the future."

The cobas e 602 module uses Roche's patented electrochemiluminescence (ECL) technology and includes more than 50 assays on its initial test menu. It offers a throughput of up to 170 immunoassay tests per hour and when combined with the existing clinical chemistry modules (cobas c 701 module / cobas c 502 module), 10 unique configurations are available, which offer a throughput of 3,670 to 7,970 tests per hour.  The cobas e 602 module is also available in 4 immunoassay only configurations, which offer a throughput of 170 to 680 tests per hour.

About the cobas 8000 modular analyzer seriesThe cobas 8000 series is the newest member of the Roche cobas modular platform family, combining both clinical chemistry and immunochemistry testing, and completes the Roche cobas portfolio for laboratories with low, medium and high testing volumes. The cobas 8000 series is designed to meet the needs of high-volume laboratories to deliver high quality results fast and efficiently from a single patient sample. It features intelligent sample routing with fast transportation and return lines, independent processing lines within each module, and a module sample buffer in each module for true random-access sampling. The series also uses the same operator interface and the standardized reagent cassette concept used on other cobas analyzer platforms. Tests run on the new platform give physicians important clinical information in a wide range of medical areas, such as cardiac and infectious diseases, bone disorders and cancer.

About RocheHeadquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80,000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: or

All trademarks used or mentioned in this release are protected by law.

For further information, please contact: Betsy Cox Director, Corporate Communications

Roche Diagnostics Corporation

Indianapolis, IN(317)

SOURCE Roche Diagnostics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010
2. Roche Receives FDA Approval for a Second-Generation Hepatitis C Viral Load Test
3. Roche Acquires RALS IT Connectivity Assets to Strengthen Presence in Point-of-Care Information Management
4. Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer
5. Roche Diagnostics Supports Fight Against MRSA as a Sponsor of Annual World MRSA Day
6. Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test
7. AstraZeneca Joins Rochester Initiative to Further Cardiac Safety
8. Roche Launches New Initiative - Roche Goes to Town
9. Roche Diagnostics Introduces Full Line of 9-Minute STAT Assays for Cardiac Biomarker Testing on cobas 6000 Analyzer Series
10. Roche Receives FDA Clearance for U.S. Launch of cobas 8000 Modular Analyzer Series for High-Volume Laboratory Testing
11. New England Biolabs Launches NEBNext™ Quick DNA Sample Prep Reagent Sets for Use With Roche/454 Next Generation Sequencing Platforms
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
Breaking Medicine News(10 mins):